Case Study
Rapid Road to Qualification: A Breakthrough Story Against Time
Cell therapy development can feel like it’s all roadblock and no road. You might face Gene knockout (KO) inefficiencies even with precision tools and techniques, then improve efficiency only to get multiple failed runs during scale-up. And all the while, patients are waiting for you to make the journey.
Hear from Joan Foster, Principal Field Application Scientist, as she shares how her dedication and scientific expertise helped a stealth mode cell therapy company overcome a critical challenge and successfully reach their next inflection point.
Joan Foster, PhD
Principal Field Application Scientist
Leverage MaxCyte’s pioneering expertise in cell therapy to accelerate product development and de-risk manufacturing
Employing our clinically-validated electroporation platform you can expedite process optimization and seamlessly transition to the clean room.
Our meticulously designed consumables maximize cell recovery to help achieve therapeutic dose.
With partnerships established with 25 leading biotech companies, our unmatched scientific and regulatory support help you navigate technical and regulatory hurdles.
Understanding Flow Electroporation
Electroporation is a non-viral transfection technique that uses electricity to relax cell membranes, allowing payload to enter. Our Flow Electroporation technology is uniquely designed to allow cells to flow through the processing chamber where discrete volumes are electroporated, then collected on a continual basis. This pioneering innovation makes genetic engineering at large scale a reality.
